当前位置: X-MOL 学术J Nucl. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and Imaging
The Journal of Nuclear Medicine ( IF 9.1 ) Pub Date : 2018-03-01 , DOI: 10.2967/jnumed.117.191221
Sridhar Nimmagadda , Mrudula Pullambhatla , Ying Chen , Princy Parsana , Ala Lisok , Samit Chatterjee , Ronnie Mease , Steven P. Rowe , Shawn Lupold , Kenneth J. Pienta , Martin G. Pomper

Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer and within the neovasculature of other solid tumors. The nonprostatic expression of PSMA has been reported exclusively within the neovasculature endothelial cells of nonprostatic cancers; however, there are few reports on PSMA expression in epithelial cells. Herein, we describe PSMA expression in nonprostatic epithelial cells and characterize the potential of PSMA-binding agents to noninvasively detect that expression. Methods: PSMA expression data were extracted from publicly available genomic databases. Genomic data were experimentally validated for PSMA expression—by quantitative reverse transcription polymerase chain reaction, flow cytometry, and Western blotting—in several nonprostatic cell lines and xenografts of melanoma and small cell lung cancer (SCLC) origin. The feasibility of PSMA detection in those tumor models was further established using PSMA-based nuclear and optical imaging agents and by biodistribution, blocking, and ex vivo molecular characterization studies. Results: We discovered that a small percentage of nonprostatic cancer cell lines and tumors express PSMA. Importantly, PSMA expression was sufficiently high to image established melanoma and SCLC xenografts using PSMA-based nuclear and optical imaging agents. Conclusion: These results indicate that PSMA expression in nonprostatic tumors may not be limited to the endothelium but may also include solid tumor tissue of nonprostatic cancers including melanoma and SCLC. Our observations indicate broader applicability of PSMA-targeted imaging and therapeutics.



中文翻译:

非前列腺肿瘤异种移植物中的低水平内源性PSMA表达足以用于体内肿瘤靶向和成像

前列腺特异性膜抗原(PSMA)在前列腺癌和其他实体瘤的新脉管系统中高度表达。仅在非前列腺癌的新血管系统内皮细胞中报告了PSMA的非前列腺表达。然而,关于PSMA在上皮细胞中表达的报道很少。在本文中,我们描述了非前列腺上皮细胞中的PSMA表达,并描述了PSMA结合剂无创检测该表达的潜力。方法:PSMA表达数据是从可公开获得的基因组数据库中提取的。通过定量逆转录聚合酶链反应,流式细胞仪和Western blotting,在几种非前列腺细胞系以及黑色素瘤和小细胞肺癌(SCLC)来源的异种移植物中,通过基因组数据对PSMA表达进行了实验验证。使用基于PSMA的核成像和光学成像剂,以及通过生物分布,阻断和离体分子表征研究,进一步确定了在这些肿瘤模型中进行PSMA检测的可行性。结果:我们发现一小部分非前列腺癌细胞系和肿瘤表达PSMA。重要的是,PSMA表达足够高,可以使用基于PSMA的核成像和光学成像剂对已建立的黑色素瘤和SCLC异种移植进行成像。结论:这些结果表明,非前列腺癌中的PSMA表达可能不仅限于内皮,还可能包括非前列腺癌的实体瘤组织,包括黑色素瘤和SCLC。我们的观察结果表明,针对PSMA的影像学和治疗学具有更广泛的适用性。

更新日期:2018-03-01
down
wechat
bug